The University of Arizona Health Sciences has selected the design-build team of McCarthy + SmithGroup to develop the Center for Advanced Molecular and Immunological Therapies, or CAMI, a biomedical research hub focused on developing biological therapies that stimulate or suppress the immune system to fight disease, located in Phoenix, Arizona.
The CAMI building is anticipated to be seven stories tall with more than 200,000 square feet of laboratory, administrative and seminar space. The laboratory space will accommodate up to 40 principal investigator-led research groups and include labs suitable for bioengineering research.
November 2024 is the anticipated groundbreaking date for the new building, which will be operational by mid-2027, though CAMI research may begin sooner than that. The second floor of the Biomedical Sciences Partnership Building is being built out to house laboratory and administrative space for CAMI, with construction scheduled to be completed in May 2024.
The center will serve as the anchor for an innovation district that aims to differentiate Phoenix from other emerging life sciences hubs, establishing the Phoenix Bioscience Core as a hub of cellular and gene therapy research, startup activity and corporate engagement.
CAMI will advance precision medicine in four areas: cancer, infectious diseases, autoimmune conditions and real-time immune monitoring and profiling. The center builds on the idea that the most effective defense against health issues is the body’s natural immune system.
Join our thriving community of 70,000+ superintendents and trade professionals on LinkedIn!
Search our job board for your next opportunity, or post an opening within your company.
Subscribe to our monthly
Construction Superintendent eNewsletter and stay current. 
